Suchergebnisse - "Nakagawa, Kazuhiko"

PubPharm (997)

1

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

2

The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma

enthalten in: JTO clinical and research reports | 2024

von Kanemura, H. | Yokoyama, T. | Nakajima, R. | +27

3

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mok, T. | Nakagawa, K. | Park, K. | +20

4

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade

enthalten in: The Journal of clinical investigation | 2024

von Hayashi, H. | Chamoto, K. | Hatae, R. | +26

5

Long-term follow-up results from KEYNOTE-041 : Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma

enthalten in: The Journal of dermatology | 2024

von Yokota, K. | Takenouchi, T. | Fujisawa, Y. | +11

6

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer

enthalten in: British journal of cancer | 2024

von Haratani, K. | Nakamura, A. | Mamesaya, N. | +22

7

PROTEIN BIOMARKER AND USES THEREOF

enthalten in: Europäisches Patentamt | 2024

von SCHNEIDER MATTHIAS | BLUM SABINE | MENDELL-HARARY RENEE JEANNE | +5

8

Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA oncology | 2024

von Shiraishi, Y. | Kishimoto, J. | Sugawara, S. | +25

9

NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC : translational research of phase III IMPACT study

enthalten in: Molecular oncology | 2024

von Ikeda, S. | Tsuboi, M. | Sakai, K. | +29

10

Protein biomarker and uses thereof

enthalten in: Europäisches Patentamt | 2024

von SCHNEIDER MATTHIAS | BLUM SABINE | MENDELL-HARARY RENEE JEANNE | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[100]